Inspection prep notes
Each note gathers what inspections actually cited on one topic. The source and the document are given under every quotation.
Data and records
Batch records and contemporaneous recordingFDA looks less at whether batch records exist than at whether each step is recorded in full at the time it is performed and then reviewed. Data integrityFDA looks less at whether a data integrity policy exists than at who created a record, when, and whether it could be changed or deleted, checking this directly on instruments and documents. Following written proceduresFDA looks less at whether written procedures exist than at whether work on the floor is done as they require and whether they actually cover that work.
Laboratory
Analytical method validationFDA looks less at whether a test method is written down than at whether data show the method is suitable for testing the product in question. Calibration and preventive maintenanceFDA looks less at whether calibration and preventive maintenance procedures exist than at whether instruments and equipment are calibrated and maintained on time, across their actual range of use, with records to show it. Microbiological testingFDA looks less at whether microbiological tests were run than at whether the methods were validated and failing results were investigated on a sound basis. OOS investigationsFDA looks less at whether an OOS result occurred than at whether it was investigated on scientific grounds to find the cause, and whether it was replaced by a passing result without justification. Sampling and reserve samplesFDA looks less at whether samples were taken than at whether they represent the lot and batch and whether reserve samples are examined under a set procedure. Stability programs and expiration datingFDA looks less at whether a stability program exists on paper than at whether the labeled expiration date is supported by actual stability data and testing continues as the program requires.
Quality system
CAPAFDA looks less at whether a CAPA procedure exists than at whether a CAPA was opened for each identified problem, carried out, and kept the problem from recurring. Deviation investigations and root causeFDA looks less at whether a deviation procedure exists than at whether deviations in manufacturing, equipment and the environment are recorded on time and investigated through to a supported cause and the full extent of impact.
Sterility and contamination control
Aseptic technique and interventionsFDA looks less at whether aseptic procedures exist than at how operators actually moved during interventions. Cleanrooms: pressure differentials, HEPA and airflowFDA looks less at whether a cleanroom is installed than at whether its pressure differentials and airflow are confirmed and maintained under actual working conditions. Cross-contamination and cleaning validationFDA looks less at whether a cleaning procedure exists than at whether it has been shown to actually remove residue from equipment. Disinfection and sporicidal agentsFDA looks less at whether disinfectants are on hand than at whether they were used on cleanroom and aseptic area surfaces under the conditions shown to be effective. Environmental monitoringFDA looks less at whether environmental monitoring records exist than at whether the monitoring represents actual production conditions and whether recoveries were investigated through to the end. Media fillFDA looks less at whether a media fill was run than at whether it simulated the hardest conditions of actual production. Pharmaceutical water systemsFDA looks less at whether a water system is installed than at whether validation and monitoring confirm that it consistently produces water suitable for its use. SterilizationFDA looks less at whether sterilization equipment is in place than at whether the sterilization process is validated and its effect and the state of items after sterilization are confirmed.